Supply@Me Capital
SYME · Main Market · Industrial Goods and Services · mcap £1.9m · 0.0p
- Revenue
- £177k
- Operating profit
- −£2.3m
- Net income
- −£2.4m
- Free cash flow
- −£829k
- Net debt
- £736k
- Market cap
- £1.9m
- EV / EBIT
- –
- FCF yield
- −44.5%
- Price / book
- –
- Revenue
- £87k +123%
- Operating profit
- −£774k prior −£1.4m
- Net income
- −£841k prior −£1.4m
- Cash from operations
- −£445k prior −£2.1m
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Every line as the company printed it, newest first – each period in the latest version the company published (restated figures where a later report restated them), in its own currency and units. Italic = calculated (H2 = full year − first half). The column headings link to the announcements.
Standardised line items in £m, comparable across companies; when a later report restated a period, the later figure is shown and marked r (hover for the figure first reported). Italic = calculated (LTM, H2 = FY − H1); a year of other than 12 months is marked (15m). Hover a value for its source.
Latest report: H1 25 (six months to 30 Jun 25), published 14 Oct 25 · read the results ↗
| FY 24£000 source | FY 23£000 source | |
|---|---|---|
| Continuing operations | ||
| Revenue | 129 | 158 |
| Cost of sales | (427) | (603) |
| Gross loss | (298) | (445) |
| Administrative expenses | (2,343) | (3,678) |
| Other operating income | 312 | 498 |
| Operating loss from continuing operations before impairment charges and fair value adjustments | (2,329) | (3,625) |
| Fair value adjustments to investments | (284) | (68) |
| Impairment charges - intangible assets | (48) | (384) |
| Impairment charges - trade and other receivables | (270) | - |
| Operating loss from continuing operations | (2,931) | (4,077) |
| Finance costs | (131) | (83) |
| Loss before tax from continuing operations | (3,062) | (4,160) |
| Taxation | 139 | - |
| Loss after tax from continuing operations | (2,923) | (4,160) |
| Discontinued operations | ||
| Loss from discontinued operations | - | (185) |
| Total loss for the year | (2,923) | (4,345) |
| Other comprehensive income | ||
| Exchange differences on translating foreign operations | 259 | 304 |
| Total comprehensive loss for the year | (2,664) | (4,041) |
| Loss attributable to | ||
| Owners of the Company | (2,664) | (4,041) |
| Earnings/(loss) per share Pence Pence | ||
| Basic and diluted loss per share - continuing operations | (0.0043) | (0.0070) |
| Basic and diluted loss per share - discontinued operations | - | (0.0003) |
| Basic and diluted loss per share - total | (0.0043) | (0.0073) |
| H1 25£'000 source | H2 24£000 calc. | H1 24£'000 source | |
|---|---|---|---|
| Revenue | |||
| Cost of sales | (105) | (195) | (232) |
| Gross loss | (18) | (105) | (193) |
| Administrative expenses | (756) | (1,063) | (1,280) |
| Other operating income | 179 | 178 | 134 |
| Operating loss before impairment charges and fair value adjustments | (595) | – | (1,339) |
| Impairment charges - intangible assets | (1) | (17) | (31) |
| Impairment charges - trade and other receivables | (178) | (270) | - |
| Fair value adjustments to investments | - | (237) | (47) |
| Operating loss | (774) | – | (1,417) |
| Finance costs | (67) | (80) | (51) |
| Loss before tax | (841) | – | (1,468) |
| Taxation | - | 42 | 97 |
| Total loss after tax for the period | (841) | – | (1,371) |
| Other comprehensive income | |||
| Exchange differences on translating foreign operations | (192) | 117 | 142 |
| Total comprehensive loss for the period | (1,033) | – | (1,229) |
| Loss per share Pence Pence | |||
| Basic and diluted loss per share | (0.0012) | – | (0.0022) |
| 30 Jun 25£'000 source | 31 Dec 24£000 source | 31 Dec 23£000 source | |
|---|---|---|---|
| Non-current assets | |||
| Intangible assets and goodwill | - | - | - |
| Investment | – | - | 284 |
| Property, plant and equipment | 1 | 1 | 3 |
| Other non-current assets | – | - | 19 |
| Total non-current assets | 1 | 1 | 306 |
| Current assets | |||
| Trade and other receivables | 1,088 | 1,088 | 1,026 |
| Cash and cash equivalents | 34 | 34 | 5 |
| Receivable from related party | 52 | 52 | 847 |
| Total current assets | 1,174 | 1,174 | 1,878 |
| Total assets | 1,175 | 1,175 | 2,184 |
| Current liabilities | |||
| Trade and other payables | 4,474 | 4,474 | 4,569 |
| Borrowings from the Nuburu On-Demand Facility | - | – | – |
| Total current liabilities | 4,474 | 4,474 | 4,569 |
| Net current liabilities | (3,300) | (3,300) | (2,691) |
| Non-current liabilities | |||
| Long-term borrowings | 364 | 364 | 840 |
| Provisions | 577 | 577 | 575 |
| Deferred tax liabilities | 6 | 6 | 7 |
| Total non-current liabilities | 947 | 947 | 1,422 |
| Net liabilities | (4,246) | (4,246) | (3,807) |
| Equity attributable to owners of the parent | |||
| Share capital | 6,199 | 6,199 | 5,989 |
| Share premium | 27,347 | 27,347 | 25,396 |
| Share-based payment reserve | 8,032 | 8,032 | 7,969 |
| Other reserves | (10,788) | (10,788) | (11,048) |
| Retained losses | (35,036) | (35,036) | (32,113) |
| Total equity | (4,246) | (4,246) | (3,807) |
| £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 | |||
| As at 1 January 2024 | (32,113) | – | – |
| Loss for the 6-month period | (1,371) | – | – |
| Forex retranslation difference | - | – | – |
| Total £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 | (33,484) | – | – |
| Credit to equity for issue of warrants | - | – | – |
| Exercise of Open Offer warrants | - | – | – |
| Issuance of new shares | - | – | – |
| Costs incurred in connection with the issuance of new ordinary shares | - | – | – |
| Equity settled employee share-based payment schemes | - | – | – |
| As 30 June 2024 | (33,484) | – | – |
| £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 | |||
| As at 1 January 2025 | (35,036) | – | – |
| Loss for the 6-month period | (841) | – | – |
| Forex retranslation difference | - | – | – |
| Total £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 | (35,877) | – | – |
| Issuance of new shares | - | – | – |
| Equity settled employee share-based payment schemes | - | – | – |
| As 30 June 2025 | (35,877) | – | – |
| 30 Jun 25£'000 source | 31 Dec 24£000 source | 31 Dec 23£000 source | |
|---|---|---|---|
| Non-current assets | |||
| Intangible assets and goodwill | - | - | - |
| Investment | – | - | 284 |
| Property, plant and equipment | 1 | 1 | 3 |
| Other non-current assets | – | - | 19 |
| Total non-current assets | 1 | 1 | 306 |
| Current assets | |||
| Trade and other receivables | 1,088 | 1,088 | 1,026 |
| Cash and cash equivalents | 34 | 34 | 5 |
| Receivable from related party | 52 | 52 | 847 |
| Total current assets | 1,174 | 1,174 | 1,878 |
| Total assets | 1,175 | 1,175 | 2,184 |
| Current liabilities | |||
| Trade and other payables | 4,474 | 4,474 | 4,569 |
| Borrowings from the Nuburu On-Demand Facility | - | – | – |
| Total current liabilities | 4,474 | 4,474 | 4,569 |
| Net current liabilities | (3,300) | (3,300) | (2,691) |
| Non-current liabilities | |||
| Long-term borrowings | 364 | 364 | 840 |
| Provisions | 577 | 577 | 575 |
| Deferred tax liabilities | 6 | 6 | 7 |
| Total non-current liabilities | 947 | 947 | 1,422 |
| Net liabilities | (4,246) | (4,246) | (3,807) |
| Equity attributable to owners of the parent | |||
| Share capital | 6,199 | 6,199 | 5,989 |
| Share premium | 27,347 | 27,347 | 25,396 |
| Share-based payment reserve | 8,032 | 8,032 | 7,969 |
| Other reserves | (10,788) | (10,788) | (11,048) |
| Retained losses | (35,036) | (35,036) | (32,113) |
| Total equity | (4,246) | (4,246) | (3,807) |
| £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 | |||
| As at 1 January 2024 | (32,113) | – | – |
| Loss for the 6-month period | (1,371) | – | – |
| Forex retranslation difference | - | – | – |
| Total £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 | (33,484) | – | – |
| Credit to equity for issue of warrants | - | – | – |
| Exercise of Open Offer warrants | - | – | – |
| Issuance of new shares | - | – | – |
| Costs incurred in connection with the issuance of new ordinary shares | - | – | – |
| Equity settled employee share-based payment schemes | - | – | – |
| As 30 June 2024 | (33,484) | – | – |
| £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 | |||
| As at 1 January 2025 | (35,036) | – | – |
| Loss for the 6-month period | (841) | – | – |
| Forex retranslation difference | - | – | – |
| Total £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 £ '000 | (35,877) | – | – |
| Issuance of new shares | - | – | – |
| Equity settled employee share-based payment schemes | - | – | – |
| As 30 June 2025 | (35,877) | – | – |
| FY 24£000 source | FY 23£000 source | |
|---|---|---|
| Cash flows from operating activities | ||
| Loss before interest and tax for the year from continuing operations | (2,931) | (4,077) |
| Loss before interest and tax for the year from discontinued operations | - | (115) |
| Total loss for the period before interest and tax | (2,931) | (4,192) |
| Adjustment for impairment charge | ||
| Impairment charges - intangible assets | 48 | 384 |
| Impairment charges - trade and other receivables | 270 | - |
| Adjustments for fair value on investments | ||
| Fair value adjustments to investments | 284 | 68 |
| Adjustments for non-cash acquisition related costs | ||
| Amortisation of intangible assets arising on acquisition | - | 442 |
| Foreign currency translation loss reclassified to comprehensive income | - | 62 |
| Profit on disposal of 81% of TradeFlow | - | (718) |
| Total adjustments for non-cash acquisition related costs | 602 | 238 |
| Other non-cash adjustments | 150 | 137 |
| Other depreciation and amortisation | 8 | 81 |
| Increase in provisions | 2 | 118 |
| Decrease in accrued income | 2 | 5 |
| (Increase) / decrease in trade and other receivables | (52) | 401 |
| (Decrease) in trade and other payables | (28) | (759) |
| Other (increases) / decreases in net working capital | (255) | 385 |
| Net cash flows from operations | (2,502) | (3,586) |
| Interest paid in cash | (91) | (47) |
| Cash received from Research & Development Tax Credit under the UK SME tax credit scheme | 97 | - |
| Net cash flow from operating activities | (2,496) | (3,633) |
| Cash flows from investing activities | ||
| Purchase of intangible assets | (53) | (458) |
| Other movements in non-current assets | 19 | - |
| Consideration received from related party on disposal of discontinued operations | 772 | 1,228 |
| Cash outflow on disposal of discontinued operations | - | (324) |
| Net cash flows from investing activities | 738 | 446 |
| Cash flows from financing activities | ||
| Net cash inflow from new long-term borrowings | 550 | 655 |
| Cash repayment of existing long-term borrowings | (176) | (105) |
| C ash inflow from issue of new ordinary shares | 1,553 | 2,322 |
| Cost of share issue paid in cash | (140) | (254) |
| Other finance costs paid in cash | - | (6) |
| Net cash flows from financing activities | 1,787 | 2,612 |
| Net movement in cash and cash equivalents | 29 | (575) |
| Foreign exchange differences to cash and cash equivalents on consolidation | - | (1) |
| Cash and cash equivalents at 1 January | 5 | 581 |
| Cash and cash equivalents at 31 December | 34 | 5 |
| H1 25£'000 source | H2 24£000 calc. | H1 24£'000 source | |
|---|---|---|---|
| Cash flows from operating activities | |||
| Operating loss before interest and tax | (774) | – | (1,417) |
| Adjustment for impairment charge | |||
| Impairment charges - intangible assets | 1 | 17 | 31 |
| Impairment charges - trade and other receivables | 178 | 270 | - |
| Adjustment for fair value on investments | |||
| Fair value adjustments to investments | - | 237 | 47 |
| Total adjustment for fair value on investments | 179 | – | 78 |
| Other non-cash adjustments | (82) | 81 | 69 |
| Other depreciation and amortisation | - | 3 | 5 |
| (Decrease) / increase in provisions | (11) | (5) | 7 |
| (Increase) in accrued income | (2) | – | (2) |
| Decrease / (increase) in trade and other receivables | 120 | (1) | (51) |
| Increase / (decrease) in trade and other payables | 265 | – | (661) |
| Other (increases) in net working capital | (170) | – | (107) |
| Cash flows from operations | (475) | – | (2,079) |
| Interest paid | (12) | – | (53) |
| Cash received from Research & Development Tax Credit under the UK SME tax credit scheme | 42 | 97 | - |
| Net cash flows from operating activities | (445) | – | (2,132) |
| Cash flows from investing activities | |||
| Purchase of intangible assets | (1) | (19) | (34) |
| Other movements in non-current assets | - | - | 19 |
| Consideration received from related party on disposal of discontinued operations | - | 102 | 670 |
| Net cash flows from investing activities | (1) | 83 | 655 |
| Cash flows from financing activities | |||
| Net cash inflow from related party borrowings | 475 | – | 550 |
| Cash repayment of existing long-term borrowings | (47) | (73) | (103) |
| Cash inflow from issue of new ordinary shares | - | – | 1,553 |
| Share issue costs paid in cash | - | – | (124) |
| Cash flows from financing activities | 428 | – | 1,876 |
| Net movement in cash and cash equivalents | (18) | (370) | 399 |
| Foreign exchange differences to cash and cash equivalents on consolidation | 1 | - | - |
| Cash and cash equivalents as at 1 January | 34 | – | 5 |
| Cash and cash equivalents at the end of the period | 17 | – | 404 |
| LTM Jun 25 | FY 24 | FY 23 | |
|---|---|---|---|
| Revenue to operating profit | |||
| Revenue | 0.2 | 0.1 | 0.2 |
| Gross profit | (0.1) | (0.3) | (0.4) |
| Adjusted operating profit | – | (2.3) | (3.6) |
| Operating profit | (2.3) | (2.9) | (4.1) |
| Depreciation (owned assets) | – | 0.0 | 0.0 |
| Amortisation | – | 0.0 | 0.1 |
| Share-based payments | – | 0.0 | 0.1 |
| Operating profit to net income | |||
| Fair value gains / losses | (0.2) | (0.3) | (0.1) |
| Finance costs | (0.1) | (0.1) | (0.1) |
| Profit before tax | (2.4) | (3.1) | (4.2) |
| Tax | 0.0 | 0.1 | 0.0 |
| Net income (owners) | (2.4) | (2.9) | (4.3) |
| Discontinued operations | – | 0.0 | (0.2) |
| Per share | |||
| EPS basic | (0.0p) | (0.0p) | (0.0p) |
| EPS diluted | (0.0p) | (0.0p) | (0.0p) |
| H1 25 | vs H1 24 | H2 24 | H1 24 | |
|---|---|---|---|---|
| Revenue to operating profit | ||||
| Revenue | 0.1 | n/m | 0.1 | 0.0 |
| Gross profit | (0.0) | n/m | (0.1) | (0.2) |
| Operating profit | (0.8) | n/m | (1.5) | (1.4) |
| Operating profit to net income | ||||
| Fair value gains / losses | 0.0 | n/m | (0.2) | (0.0) |
| Finance costs | (0.1) | n/m | (0.1) | (0.1) |
| Profit before tax | (0.8) | n/m | (1.6) | (1.5) |
| Tax | 0.0 | n/m | 0.0 | 0.1 |
| Net income (owners) | (0.8) | n/m | (1.6) | (1.4) |
| Per share | ||||
| EPS basic | (0.0p) | – | (0.0p) | (0.0p) |
| EPS diluted | (0.0p) | – | (0.0p) | (0.0p) |
| 30 Jun 25 | 31 Dec 24 | 31 Dec 23 | |
|---|---|---|---|
| Non-current assets | |||
| Goodwill | 0.0 | 0.0 | 0.0 |
| Property, plant & equipment | 0.0 | 0.0 | 0.0 |
| Other investments | – | 0.0 | 0.3 |
| Non-current assets | 0.0 | 0.0 | 0.3 |
| Current assets | |||
| Trade receivables | 1.0 | 1.1 | 1.0 |
| Cash | 0.0 | 0.0 | 0.0 |
| Current assets | 1.0 | 1.2 | 1.9 |
| Total assets | 1.0 | 1.2 | 2.2 |
| Current liabilities | |||
| Trade payables | 5.0 | 4.5 | 4.6 |
| Borrowings, current | 0.5 | 0.0 | – |
| Current liabilities | 5.4 | 4.5 | 4.6 |
| Non-current liabilities | |||
| Borrowings, non-current | 0.3 | 0.4 | 0.8 |
| Equity | |||
| Total equity | (5.3) | (4.2) | (3.8) |
| 30 Jun 25 | 31 Dec 24 | 31 Dec 23 | |
|---|---|---|---|
| Non-current assets | |||
| Goodwill | 0.0 | 0.0 | 0.0 |
| Property, plant & equipment | 0.0 | 0.0 | 0.0 |
| Other investments | – | 0.0 | 0.3 |
| Non-current assets | 0.0 | 0.0 | 0.3 |
| Current assets | |||
| Trade receivables | 1.0 | 1.1 | 1.0 |
| Cash | 0.0 | 0.0 | 0.0 |
| Current assets | 1.0 | 1.2 | 1.9 |
| Total assets | 1.0 | 1.2 | 2.2 |
| Current liabilities | |||
| Trade payables | 5.0 | 4.5 | 4.6 |
| Borrowings, current | 0.5 | 0.0 | – |
| Current liabilities | 5.4 | 4.5 | 4.6 |
| Non-current liabilities | |||
| Borrowings, non-current | 0.3 | 0.4 | 0.8 |
| Equity | |||
| Total equity | (5.3) | (4.2) | (3.8) |
Read automatically from each results announcement. Check the source before relying on a figure.
Company filings. Not investment advice.